27676379|t|Postprandial anti-hyperglycemic activity of marine Streptomyces coelicoflavus SRBVIT13 mediated gold nanoparticles in streptozotocin induced diabetic male albino Wister rats
27676379|a|The present study focuses on the biosynthesis of gold nanoparticles (AuNPs) using Streptomyces coelicoflavus (S. coelicoflavus) SRBVIT13 isolated from marine salt pan soils collected from Ongole, Andhra Pradesh, India. The biosynthesised AuNPs are characterised by UV-visible spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy, high-resolution transmission electron microscopy and energy-dispersive X-ray analysis. Transmission electron microscopy study suggests that the biosynthesised AuNPs are spherical in shape within a size range of 12-20 nm (mean diameter as 14 nm). The anti-type II diabetes activity of AuNPs is carried out by testing it in vitro α-glucosidase and α-amylase enzyme inhibition activity and in vivo postprandial anti-hyperglycemic activity in sucrose and glucose -loaded streptozotocin induced diabetic albino Wister rats. AuNPs has shown a significant inhibitory activity of 84.70 and 87.82% with IC50 values of 67.65 and 65.59 μg/mL to α-glucosidase and α-amylase enzymes, while the diabetic rats have shown significant reduction in the post postprandial blood glucose level by 57.80 and 88.09%, respectively compared with control group after AuNPs treatment at the concentration of 300 and 600 mg/kg body weight. Hence, this biosynthesised AuNPs might be useful in combating type II diabetes mellitus for the betterment of human life.
27676379	0	12	Postprandial	T079	C0376674
27676379	13	40	anti-hyperglycemic activity	T033	C2825141
27676379	44	50	marine	T001	C0599383
27676379	51	86	Streptomyces coelicoflavus SRBVIT13	T007	C1656173
27676379	96	100	gold	T121,T196	C0018026
27676379	101	114	nanoparticles	T073	C1721060
27676379	118	132	streptozotocin	T109,T195	C0038432
27676379	133	140	induced	T169	C0205263
27676379	141	149	diabetic	T047	C0011847
27676379	150	154	male	T032	C0086582
27676379	155	173	albino Wister rats	T015	C0034716
27676379	207	219	biosynthesis	T169	C0005572
27676379	223	227	gold	T121,T196	C0018026
27676379	228	241	nanoparticles	T073	C1721060
27676379	243	248	AuNPs	T073	C1721060
27676379	256	310	Streptomyces coelicoflavus (S. coelicoflavus) SRBVIT13	T007	C1656173
27676379	311	319	isolated	T169	C0205409
27676379	325	346	marine salt pan soils	T167	C0037592
27676379	362	368	Ongole	UnknownType	C0681784
27676379	370	384	Andhra Pradesh	UnknownType	C0681784
27676379	386	391	India	T083	C0021201
27676379	397	411	biosynthesised	T169	C0005572
27676379	412	417	AuNPs	T073	C1721060
27676379	422	435	characterised	T062	C1881968
27676379	439	462	UV-visible spectroscopy	T059	C0037812
27676379	464	481	X-ray diffraction	T059	C0043301
27676379	483	522	Fourier transform infrared spectroscopy	T062	C0206055
27676379	524	572	high-resolution transmission electron microscopy	T059	C2697588
27676379	577	609	energy-dispersive X-ray analysis	T059	C0599643
27676379	611	643	Transmission electron microscopy	T059	C0678118
27676379	668	682	biosynthesised	T169	C0005572
27676379	683	688	AuNPs	T073	C1721060
27676379	693	711	spherical in shape	T082	C0332501
27676379	721	725	size	T082	C0456389
27676379	745	758	mean diameter	T081	C0552409
27676379	774	804	anti-type II diabetes activity	T033	C2825141
27676379	808	813	AuNPs	T073	C1721060
27676379	832	839	testing	T169	C0039593
27676379	843	851	in vitro	T080	C1533691
27676379	852	865	α-glucosidase	T116,T121,T126	C0002272
27676379	870	879	α-amylase	T116,T121,T126	C3853624
27676379	880	906	enzyme inhibition activity	T040	C2248397
27676379	911	918	in vivo	T082	C1515655
27676379	919	931	postprandial	T079	C0376674
27676379	932	959	anti-hyperglycemic activity	T033	C2825141
27676379	963	970	sucrose	T109,T121,T123	C0038636
27676379	975	982	glucose	T109,T121,T123	C0017725
27676379	991	1005	streptozotocin	T109,T195	C0038432
27676379	1006	1013	induced	T169	C0205263
27676379	1014	1022	diabetic	T047	C0011847
27676379	1023	1041	albino Wister rats	T015	C0034716
27676379	1043	1048	AuNPs	T073	C1721060
27676379	1073	1092	inhibitory activity	T040	C2248397
27676379	1118	1122	IC50	T081	C0600495
27676379	1158	1171	α-glucosidase	T116,T121,T126	C0002272
27676379	1176	1185	α-amylase	T116,T121,T126	C3853624
27676379	1186	1193	enzymes	T116,T126	C0014442
27676379	1205	1213	diabetic	T047	C0011847
27676379	1214	1218	rats	T015	C0034693
27676379	1242	1251	reduction	T080	C0392756
27676379	1264	1276	postprandial	T079	C0376674
27676379	1277	1296	blood glucose level	T034	C0428554
27676379	1345	1358	control group	T096	C0009932
27676379	1365	1370	AuNPs	T073	C1721060
27676379	1371	1380	treatment	T169	C1522326
27676379	1388	1401	concentration	T081	C0392762
27676379	1417	1434	mg/kg body weight	T081	C0560741
27676379	1448	1462	biosynthesised	T169	C0005572
27676379	1463	1468	AuNPs	T073	C1721060
27676379	1498	1523	type II diabetes mellitus	T047	C0011860
27676379	1546	1551	human	T016	C0086418
27676379	1552	1556	life	T078	C0376558